IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $796,000 | -0.3% | 49,425 | -21.6% | 0.22% | +113.7% |
Q1 2017 | $798,000 | -14.3% | 63,076 | +95.3% | 0.10% | -16.4% |
Q2 2016 | $931,000 | +266.5% | 32,300 | +307.1% | 0.12% | +306.7% |
Q1 2016 | $254,000 | -45.0% | 7,934 | -26.5% | 0.03% | -26.8% |
Q4 2015 | $462,000 | -70.0% | 10,800 | -67.2% | 0.04% | -73.9% |
Q1 2015 | $1,542,000 | +356.2% | 32,910 | +207.6% | 0.16% | +161.7% |
Q4 2014 | $338,000 | – | 10,700 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |